SANDRA KURTIN, PhD, ANP-C, AOCN®
University of Arizona and University of Arizona Cancer Center
Greetings, and welcome to JADPRO Benign Hematology Updates. I hope you will explore and engage with the full array of resources that we’ve developed for our advanced practitioner (AP) audience on management approaches to a broad range of disease states in the evolving field of benign blood disorders. APs play a critical role in the multidisciplinary care of these conditions—which can be inherited or acquired; chronic and mild or acute and life-threatening; are often rare; and may be challenging to diagnose. Comprehensive differential diagnosis is critical since the patients’ symptoms may be incorrectly attributed to inconsequential causes. These often-complex disorders may occur in conjunction with or as a result of cancer, and in some cases may transform into malignancies.
Complicating today’s management of benign hematologic disorders, of course, is the challenge of COVID-19, declared as a pandemic by the World Health Organization just a year ago, in March 2020. As we have learned, COVID-19 can manifest with acute vascular effects such as micro-occlusions, and “long haul” COVID survivors may experience key symptoms (such as chronic fatigue) that often manifest in our patients with blood disorders. Ongoing research and our own experience have shown that patients with inherited or acquired benign hematologic disorders are at increased risk of severe COVID-19. The impact of this emerging clinical challenge, which will likely continue in the near future even with ongoing rollout and uptake of the SARS-CoV-2 vaccine, will be explored in the current JADPRO Benign Hematology Updates program, which is planned to run through March 2022, with content refreshed regularly.
This comprehensive program is organized into four broad topic areas, each guided by a dedicated specialist or specialist team: Hereditary/Acquired Bleeding Disorders, led by Jennifer Donkin, PNP, DNP, from the Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles; Autoimmune Cytopenias, led by David Hughes, PharmD, BCOP, and Frances Blevins, PA-C, from Boston Medical Center; Hemoglobinopathies, led by Susan Carson, RN, MSN, CPNP, from the Children’s Center for Cancer and Blood Diseases, Children’s Hospital Los Angeles; and Bone Marrow Failure Disorders, led by Natasha Johnson, MSN, APRN, AOCNP, from Moffitt Cancer Center.
This microsite offers a selection of important clinical studies and best-practice resources; my comprehensive Benign Hematology Basics presentation; Fast Facts, with essential information on current diagnosis, treatment, supportive care, and prognosis of selected benign blood disorders; case studies from practitioners working in a variety of clinical settings; and video discussions in which expert APs share their tips and perspectives on challenging aspects of care. The program faculty and I look forward to sharing our years of experience and practice pearls with you.
Learn more about our program launch, as well as other planned content for this special series, in my welcome video.
I look forward to sharing new content with you on a monthly basis, as we develop this expanding resource further. Please feel free to contact me via email@example.com with your comments and questions.
Frontiers in Physiology
Frontiers in Physiology